NEW YORK, Oct. 13 (GenomeWeb News) - Dutch biotech Galapagos has acquired around 77 percent of BioFocus as part of its deal to buy the company, and will obtain the remaining 24 percent over the coming weeks, a Galapagos official said today.
The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.
